Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib.

× No keyword cloud information.

10 in total

1. Cutaneous Leukocytoclastic Vasculitis Associated with Erlotinib.

Authors: Takahiro Sawada; Mitsuhiro Suehiro; Osamu Hiranuma
Journal: Indian J Dermatol Date: 2016 Mar-Apr Impact factor: 1.494

Review 2. [MRI alterations in immunomodulation].

Authors: K Guggenberger; H Urbach
Journal: Nervenarzt Date: 2018-08 Impact factor: 1.214

Review 3. Myelodysplasia and malignancy-associated vasculitis.

Authors: Amir Agha; Helen Bateman; Ashley Sterrett; Joanne Valeriano-Marcet
Journal: Curr Rheumatol Rep Date: 2012-12 Impact factor: 4.592

4. Successful rechallenge with reduced dose of erlotinib in a patient with lung adenocarcinoma who developed erlotinib-associated leukocytoclastic vasculitis: A case report.

Authors: Bo-An Su; Wan-Lin Shen; Sheng-Tsung Chang; Li-Yia Feng; Chia-Jung Wu; Yin-Hsun Feng
Journal: Oncol Lett Date: 2012-03-16 Impact factor: 2.967

5. Cutaneous vasculitis in breast cancer treated with chemotherapy.

Authors: Maida Wong; Jennifer Grossman; Bevra H Hahn; Antonio La Cava
Journal: Clin Immunol Date: 2008-07-21 Impact factor: 3.969

6. Leukocytoclastic vasculitis after long-term treatment with sunitinib: a case report.

Authors: Alexandra Karadimou; Magdalini Migou; Afroditi Economidi; Alexandros Stratigos; Christos Kittas; Meletios A Dimopoulos; Aristotle Bamias
Journal: Case Rep Oncol Date: 2011-08-18

7. Crescentic glomerulonephritis in a patient with advanced lung cancer during erlotinib therapy.

Authors: Noriaki Kurita; Naobumi Mise; Akiko Fujii; Shingo Ikeda; Tokuichiro Sugimoto
Journal: NDT Plus Date: 2009-12

8. Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion protein.

Authors: Tamio Okimoto; Yukari Tsubata; Takamasa Hotta; Megumi Hamaguchi; Takae Okuno; Yohei Shiratsuki; Akari Kodama; Mika Nakao; Yoshihiro Amano; Shunichi Hamaguchi; Noriaki Kurimoto; Reiko Tobita; Takeshi Isobe
Journal: Oncotarget Date: 2018-04-13

9. Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report.

Authors: Maria Massucci; Veronica Mollica; Alessandro Rizzo; Laura Ventrella; Ilaria Maggio; Lisa Manuzzi; Lidia Gatto; Giovanni Brandi; Francesco Massari
Journal: Medicines (Basel) Date: 2021-01-11

10. Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors.

Authors: Xuan Huang; Samir Patel; Nasir Ahmed; Karen Seiter; Delong Liu
Journal: Drug Des Devel Ther Date: 2009-02-06 Impact factor: 4.162

10 in total